853 related articles for article (PubMed ID: 27716745)
1. The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
Li Z; Hou P; Fan D; Dong M; Ma M; Li H; Yao R; Li Y; Wang G; Geng P; Mihretab A; Liu D; Zhang Y; Huang B; Lu J
Cell Death Differ; 2017 Jan; 24(1):59-71. PubMed ID: 27716745
[TBL] [Abstract][Full Text] [Related]
2. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
Zhang KJ; Tan XL; Guo L
Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-ANCR regulates the cell growth of osteosarcoma by interacting with EZH2 and affecting the expression of p21 and p27.
Zhang F; Peng H
J Orthop Surg Res; 2017 Jul; 12(1):103. PubMed ID: 28679390
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA anti-differentiation non-coding RNA affects proliferation, invasion, and migration of breast cancer cells by targeting miR-331.
Jiang C; Shi X; Yi D; Wang R; Xu F; Guan W; Sang J
Bioengineered; 2021 Dec; 12(2):12236-12245. PubMed ID: 34783641
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-ANCR down-regulation suppresses invasion and migration of colorectal cancer cells by regulating EZH2 expression.
Yang ZY; Yang F; Zhang YL; Liu B; Wang M; Hong X; Yu Y; Zhou YH; Zeng H
Cancer Biomark; 2017; 18(1):95-104. PubMed ID: 27983539
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression.
Cheng C; Dong Y; Ru X; Xia Y; Ji Y
Cancer Gene Ther; 2021 Sep; 28(9):1025-1034. PubMed ID: 33293663
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of long noncoding RNA FERRE promoted growth and invasion of breast cancer through modulating miR-19a-5p/EZH2 axis.
Lin Y; Wu T; Yang M; Duangmano S; Chaiwongsa R; Pornprasert S; He T
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11154-11164. PubMed ID: 33215433
[TBL] [Abstract][Full Text] [Related]
9. Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2.
Cai N; Li C; Wang F
Yonsei Med J; 2019 Aug; 60(8):751-759. PubMed ID: 31347330
[TBL] [Abstract][Full Text] [Related]
10. Repression of PDK1- and LncRNA HOTAIR-Mediated EZH2 Gene Expression Contributes to the Enhancement of Atractylenolide 1 and Erlotinib in the Inhibition of Human Lung Cancer Cells.
Xiao Q; Zheng F; Tang Q; Wu JJ; Xie J; Huang HD; Yang XB; Hann SS
Cell Physiol Biochem; 2018; 49(4):1615-1632. PubMed ID: 30223276
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of Long Noncoding RNA HOTAIR and EZH2 Induces Apoptosis and Inhibits Proliferation, Invasion, and Migration of Human Breast Cancer Cells.
Han L; Zhang HC; Li L; Li CX; Di X; Qu X
Cancer Biother Radiopharm; 2018 Aug; 33(6):241-251. PubMed ID: 30048163
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ANCR Promotes Invasion and Migration of Gastric Cancer by Regulating FoxO1 Expression to Inhibit Macrophage M1 Polarization.
Xie C; Guo Y; Lou S
Dig Dis Sci; 2020 Oct; 65(10):2863-2872. PubMed ID: 31894487
[TBL] [Abstract][Full Text] [Related]
13. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.
Chen MJ; Deng J; Chen C; Hu W; Yuan YC; Xia ZK
Int J Biochem Cell Biol; 2019 Aug; 113():27-36. PubMed ID: 31102664
[TBL] [Abstract][Full Text] [Related]
14. LncRNA DLG5-AS1 facilitates breast cancer cell proliferation and invasion by promoting EZH2-mediated transcriptional silencing of SFRP1.
Cai Y; Liu Y; Sun Y; Ren Y
Arch Biochem Biophys; 2024 Jun; 756():110018. PubMed ID: 38677505
[TBL] [Abstract][Full Text] [Related]
15. Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis.
Li Z; Wang D; Lu J; Huang B; Wang Y; Dong M; Fan D; Li H; Gao Y; Hou P; Li M; Liu H; Pan ZQ; Zheng J; Bai J
Cell Death Differ; 2020 Dec; 27(12):3226-3242. PubMed ID: 32895488
[TBL] [Abstract][Full Text] [Related]
16. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA cancer susceptibility candidate 9 promotes doxorubicin‑resistant breast cancer by binding to enhancer of zeste homolog 2.
Jiang B; Li Y; Qu X; Zhu H; Tan Y; Fan Q; Jiang Y; Liao M; Wu X
Int J Mol Med; 2018 Nov; 42(5):2801-2810. PubMed ID: 30106089
[TBL] [Abstract][Full Text] [Related]
18. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
19. EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.
Han T; Jiao F; Hu H; Yuan C; Wang L; Jin ZL; Song WF; Wang LW
Oncotarget; 2016 Mar; 7(10):11194-207. PubMed ID: 26848980
[TBL] [Abstract][Full Text] [Related]
20. Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression.
Zang X; Gu J; Zhang J; Shi H; Hou S; Xu X; Chen Y; Zhang Y; Mao F; Qian H; Zhu T; Xu W; Zhang X
Cell Death Dis; 2020 Apr; 11(4):215. PubMed ID: 32242003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
